merkel cell cancer
Showing 1 - 25 of >10,000
Merkel Cell Carcinoma Trial (Pembrolizumab, Lutetium Lu 177 dotatate)
Not yet recruiting
- Merkel Cell Carcinoma
- Pembrolizumab
- Lutetium Lu 177 dotatate
- (no location specified)
Oct 12, 2022
Stage III Merkel Cell Carcinoma AJCC v8, Stage IIIB Merkel Cell Carcinoma AJCC v8, Stage IIIA Merkel Cell Carcinoma AJCC v8
Recruiting
- Stage III Merkel Cell Carcinoma AJCC v8
- +2 more
- Avelumab
- +2 more
-
Orange, California
- +10 more
Jan 30, 2023
Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell
Not yet recruiting
- Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +5 more
- Avelumab
- +6 more
- (no location specified)
Jul 13, 2023
Merkel Cell Carcinoma, Neuroendocrine Carcinoma of the Skin, Trabecular Carcinoma of the Skin Trial in Tampa (Lenvatinib Oral
Recruiting
- Merkel Cell Carcinoma
- +2 more
- Lenvatinib Oral Product
- Pembrolizumab
-
Tampa, FloridaMoffitt Cancer Center
Dec 30, 2022
Recurrent Merkel Cell Carcinoma, Stage III Merkel Cell Carcinoma AJCC v7, Stage IIIA Merkel Cell Carcinoma AJCC v7 Trial in
Completed
- Recurrent Merkel Cell Carcinoma
- +4 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Palo Alto, California
- +12 more
Mar 17, 2022
Merkel Cell Carcinoma, Skin Cancer Trial in Boston (Cabozantinib)
Active, not recruiting
- Merkel Cell Carcinoma
- Skin Cancer
-
Boston, Massachusetts
- +1 more
Jul 13, 2022
Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))
Active, not recruiting
- Merkel Cell Carcinoma
- Skin Cancer
- Nivolumab
- +2 more
-
Tampa, Florida
- +1 more
Nov 11, 2022
Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell
Not yet recruiting
- Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +2 more
- Biopsy
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 28, 2023
Merkel Cell Carcinoma Trial in Australia (Carboplatin, Etoposide, Radiotherapy)
Completed
- Merkel Cell Carcinoma
- Carboplatin
- +2 more
-
Campbelltown, New South Wales, Australia
- +12 more
Nov 17, 2022
Merkel Cell Carcinoma Trial in Seattle (ITI-3000)
Recruiting
- Merkel Cell Carcinoma
-
Seattle, WashingtonUniversity of Washington/Seattle Cancer Care Alliance
Aug 1, 2022
Merkel Cell Carcinoma, Small Cell Lung Cancer Trial in United States (XmAb18087, XmAb18087 ± Pembrolizumab)
Completed
- Merkel Cell Carcinoma
- Small Cell Lung Cancer
- XmAb18087
- XmAb18087 ± Pembrolizumab
-
Duarte, California
- +6 more
Aug 8, 2022
Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II Trial in Australia (Avelumab, Placebo)
Recruiting
- Merkel Cell Carcinoma
- +5 more
- Avelumab
- Placebo
-
Port Macquarie, New South Wales, Australia
- +17 more
Aug 30, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +20 more
- Ipilimumab
- +3 more
-
Tampa, Florida
- +6 more
Jan 13, 2023
Melanoma, Merkel Cell Carcinoma, Other Solid Tumors Trial in Middletown, Harrison, New York (TALIMOGENE LAHERPAREPVEC (TVEC),
Active, not recruiting
- Melanoma
- +2 more
- TALIMOGENE LAHERPAREPVEC (TVEC)
- Hypofractionated Radiotherapy
-
Middletown, New Jersey
- +2 more
Jul 13, 2022
Merkel Cell Carcinoma Trial in Houston (Radiation therapy)
Recruiting
- Merkel Cell Carcinoma
- Radiation therapy
-
Houston, TexasM D Anderson Cancer Center
Feb 3, 2022
Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)
Terminated
- Merkel Cell Polyomavirus Infection
- Stage IV Merkel Cell Carcinoma AJCC v7
- Avelumab
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 25, 2022
Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +
Recruiting
- Gastric Cancer
- +9 more
- Tumor Infiltrating Lymphocytes (TIL)
- Fludarabine + Cyclophosphamide combination
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 21, 2022
Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Tampa (Excerise, Checkpoint Blockade,
Recruiting
- Cutaneous Melanoma
- +2 more
- Excerise
- Checkpoint Blockade, Immune
-
Tampa, FloridaMoffitt Cancer Center
Sep 21, 2022
Melanoma, Merkel Cell Carcinoma, Unspecified, Renal Cell Carcinoma Trial in Australia, Netherlands, United States
Recruiting
- Melanoma
- +3 more
- 89Zr-Df-Crefmirlimab
-
Little Rock, Arkansas
- +7 more
Jul 11, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Not yet recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +12 more
- Biopsy
- +8 more
- (no location specified)
Jun 8, 2023
Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,
Not yet recruiting
- Diffuse Astrocytoma, IDH-Mutant
- +20 more
- NEO212 Oral Capsule
- +8 more
- (no location specified)
Sep 18, 2023
Breast Cancer, Melanoma, Non Small Cell Lung Cancer Trial in Brussel (Checkpoint Blockade, Immune)
Recruiting
- Breast Cancer
- +12 more
- Checkpoint Blockade, Immune
-
Brussel, Anderlecht, BelgiumInstitut Jules Bordet
Jul 1, 2022
Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Tampa, Durham (MEM-288 Intratumoral Injection)
Recruiting
- Solid Tumor
- +9 more
- MEM-288 Intratumoral Injection
-
Tampa, Florida
- +1 more
Jun 27, 2022